AAPL329.40-9.00 (-2.66%) ▼|ABBV263.29-2.99 (-1.12%) ▼|ABT100.95-0.03 (-0.03%) ▼|ACN177.12+2.65 (+1.52%) ▲|ADBE233.17+2.16 (+0.94%) ▲|AMAT512.01+25.25 (+5.19%) ▲|AMD607.57-0.30 (-0.05%) ▼|AMGN423.64+5.51 (+1.32%) ▲|AMT167.35-0.65 (-0.39%) ▼|AMZN246.67+0.52 (+0.21%) ▲|AVGO355.10+5.53 (+1.58%) ▲|AXP305.40-0.93 (-0.30%) ▼|BA187.68+3.29 (+1.78%) ▲|BAC54.96-0.51 (-0.92%) ▼|BKNG162.34-1.53 (-0.93%) ▼|BLK1,067.94-3.31 (-0.31%) ▼|BMY62.86-1.02 (-1.60%) ▼|BNY146.98-1.46 (-0.98%) ▼|BRK-B502.35-0.74 (-0.15%) ▼|C130.80-0.51 (-0.39%) ▼|CAT826.64+6.69 (+0.82%) ▲|CL86.46-0.06 (-0.07%) ▼|CMCSA21.60-0.19 (-0.87%) ▼|COF196.46+0.00 (+0.00%) ▲|COP125.44-0.60 (-0.48%) ▼|COST924.59+1.67 (+0.18%) ▲|CRM225.31-1.96 (-0.86%) ▼|CSCO106.94+0.20 (+0.19%) ▲|CVS87.10-0.75 (-0.85%) ▼|CVX204.38-1.99 (-0.96%) ▼|DE680.50-9.09 (-1.32%) ▼|DHR226.11-1.22 (-0.54%) ▼|DIS105.41-0.18 (-0.17%) ▼|DUK114.21+0.80 (+0.71%) ▲|EMR157.24-2.15 (-1.35%) ▼|FDX287.47-2.18 (-0.75%) ▼|GD332.34-1.82 (-0.54%) ▼|GE317.89-0.35 (-0.11%) ▼|GEV962.49+12.72 (+1.34%) ▲|GILD151.28-0.93 (-0.61%) ▼|GM80.47-0.17 (-0.21%) ▼|GOOG337.32-1.84 (-0.54%) ▼|GOOGL340.92-1.83 (-0.53%) ▼|GS916.24-0.04 (0.00%) ▼|HD288.04-1.85 (-0.64%) ▼|HON210.13-1.39 (-0.66%) ▼|IBM219.99-0.68 (-0.31%) ▼|INTC115.93-0.10 (-0.09%) ▼|INTU268.03-1.37 (-0.51%) ▼|ISRG412.18-2.61 (-0.63%) ▼|JNJ267.57-4.38 (-1.61%) ▼|JPM334.98-1.61 (-0.48%) ▼|KO86.84-0.34 (-0.39%) ▼|LIN473.37+1.33 (+0.28%) ▲|LLY1,184.63-0.15 (-0.01%) ▼|LMT512.21-5.89 (-1.14%) ▼|LOW187.26-0.40 (-0.21%) ▼|LRCX323.86+9.39 (+2.99%) ▲|MA563.58-4.68 (-0.82%) ▼|MCD233.98+0.38 (+0.16%) ▲|MDLZ59.32-0.86 (-1.43%) ▼|MDT87.09-2.41 (-2.69%) ▼|META738.79+23.17 (+3.24%) ▲|MMM168.49-0.99 (-0.58%) ▼|MO68.72-0.41 (-0.59%) ▼|MRK149.28+0.59 (+0.40%) ▲|MS192.76-0.88 (-0.45%) ▼|MSFT508.96-0.26 (-0.05%) ▼|MU1,065.08+11.10 (+1.05%) ▲|NEE75.89+0.40 (+0.53%) ▲|NFLX70.30+1.07 (+1.55%) ▲|NKE35.84-0.55 (-1.51%) ▼|NOW129.94-1.51 (-1.15%) ▼|NVDA227.21-1.65 (-0.72%) ▼|ORCL137.79+5.19 (+3.91%) ▲|PEP128.69+0.19 (+0.15%) ▲|PFE28.72+0.00 (+0.00%) ▲|PG148.32-0.71 (-0.48%) ▼|PLTR186.97-0.51 (-0.27%) ▼|PM193.90+0.14 (+0.07%) ▲|QCOM184.10-3.38 (-1.80%) ▼|RTX186.94-0.72 (-0.38%) ▼|SBUX95.43+0.16 (+0.17%) ▲|SCHW99.10+0.80 (+0.81%) ▲|SO83.45+1.10 (+1.34%) ▲|SPG204.28-0.25 (-0.12%) ▼|T24.48-0.42 (-1.69%) ▼|TMO679.61+1.01 (+0.15%) ▲|TMUS162.98-3.47 (-2.08%) ▼|TSLA352.84-4.61 (-1.29%) ▼|TXN281.69+3.38 (+1.21%) ▲|UBER69.36+1.20 (+1.76%) ▲|UNH374.94-2.89 (-0.76%) ▼|UNP274.15+0.05 (+0.02%) ▲|UPS93.93-0.32 (-0.34%) ▼|USB58.14-0.64 (-1.09%) ▼|V365.88-1.86 (-0.51%) ▼|VZ45.98-0.70 (-1.50%) ▼|WFC80.48-0.33 (-0.41%) ▼|WMT106.80-1.93 (-1.78%) ▼|XOM161.35-1.17 (-0.72%) ▼|AAPL329.40-9.00 (-2.66%) ▼|ABBV263.29-2.99 (-1.12%) ▼|ABT100.95-0.03 (-0.03%) ▼|ACN177.12+2.65 (+1.52%) ▲|ADBE233.17+2.16 (+0.94%) ▲|AMAT512.01+25.25 (+5.19%) ▲|AMD607.57-0.30 (-0.05%) ▼|AMGN423.64+5.51 (+1.32%) ▲|AMT167.35-0.65 (-0.39%) ▼|AMZN246.67+0.52 (+0.21%) ▲|AVGO355.10+5.53 (+1.58%) ▲|AXP305.40-0.93 (-0.30%) ▼|BA187.68+3.29 (+1.78%) ▲|BAC54.96-0.51 (-0.92%) ▼|BKNG162.34-1.53 (-0.93%) ▼|BLK1,067.94-3.31 (-0.31%) ▼|BMY62.86-1.02 (-1.60%) ▼|BNY146.98-1.46 (-0.98%) ▼|BRK-B502.35-0.74 (-0.15%) ▼|C130.80-0.51 (-0.39%) ▼|CAT826.64+6.69 (+0.82%) ▲|CL86.46-0.06 (-0.07%) ▼|CMCSA21.60-0.19 (-0.87%) ▼|COF196.46+0.00 (+0.00%) ▲|COP125.44-0.60 (-0.48%) ▼|COST924.59+1.67 (+0.18%) ▲|CRM225.31-1.96 (-0.86%) ▼|CSCO106.94+0.20 (+0.19%) ▲|CVS87.10-0.75 (-0.85%) ▼|CVX204.38-1.99 (-0.96%) ▼|DE680.50-9.09 (-1.32%) ▼|DHR226.11-1.22 (-0.54%) ▼|DIS105.41-0.18 (-0.17%) ▼|DUK114.21+0.80 (+0.71%) ▲|EMR157.24-2.15 (-1.35%) ▼|FDX287.47-2.18 (-0.75%) ▼|GD332.34-1.82 (-0.54%) ▼|GE317.89-0.35 (-0.11%) ▼|GEV962.49+12.72 (+1.34%) ▲|GILD151.28-0.93 (-0.61%) ▼|GM80.47-0.17 (-0.21%) ▼|GOOG337.32-1.84 (-0.54%) ▼|GOOGL340.92-1.83 (-0.53%) ▼|GS916.24-0.04 (0.00%) ▼|HD288.04-1.85 (-0.64%) ▼|HON210.13-1.39 (-0.66%) ▼|IBM219.99-0.68 (-0.31%) ▼|INTC115.93-0.10 (-0.09%) ▼|INTU268.03-1.37 (-0.51%) ▼|ISRG412.18-2.61 (-0.63%) ▼|JNJ267.57-4.38 (-1.61%) ▼|JPM334.98-1.61 (-0.48%) ▼|KO86.84-0.34 (-0.39%) ▼|LIN473.37+1.33 (+0.28%) ▲|LLY1,184.63-0.15 (-0.01%) ▼|LMT512.21-5.89 (-1.14%) ▼|LOW187.26-0.40 (-0.21%) ▼|LRCX323.86+9.39 (+2.99%) ▲|MA563.58-4.68 (-0.82%) ▼|MCD233.98+0.38 (+0.16%) ▲|MDLZ59.32-0.86 (-1.43%) ▼|MDT87.09-2.41 (-2.69%) ▼|META738.79+23.17 (+3.24%) ▲|MMM168.49-0.99 (-0.58%) ▼|MO68.72-0.41 (-0.59%) ▼|MRK149.28+0.59 (+0.40%) ▲|MS192.76-0.88 (-0.45%) ▼|MSFT508.96-0.26 (-0.05%) ▼|MU1,065.08+11.10 (+1.05%) ▲|NEE75.89+0.40 (+0.53%) ▲|NFLX70.30+1.07 (+1.55%) ▲|NKE35.84-0.55 (-1.51%) ▼|NOW129.94-1.51 (-1.15%) ▼|NVDA227.21-1.65 (-0.72%) ▼|ORCL137.79+5.19 (+3.91%) ▲|PEP128.69+0.19 (+0.15%) ▲|PFE28.72+0.00 (+0.00%) ▲|PG148.32-0.71 (-0.48%) ▼|PLTR186.97-0.51 (-0.27%) ▼|PM193.90+0.14 (+0.07%) ▲|QCOM184.10-3.38 (-1.80%) ▼|RTX186.94-0.72 (-0.38%) ▼|SBUX95.43+0.16 (+0.17%) ▲|SCHW99.10+0.80 (+0.81%) ▲|SO83.45+1.10 (+1.34%) ▲|SPG204.28-0.25 (-0.12%) ▼|T24.48-0.42 (-1.69%) ▼|TMO679.61+1.01 (+0.15%) ▲|TMUS162.98-3.47 (-2.08%) ▼|TSLA352.84-4.61 (-1.29%) ▼|TXN281.69+3.38 (+1.21%) ▲|UBER69.36+1.20 (+1.76%) ▲|UNH374.94-2.89 (-0.76%) ▼|UNP274.15+0.05 (+0.02%) ▲|UPS93.93-0.32 (-0.34%) ▼|USB58.14-0.64 (-1.09%) ▼|V365.88-1.86 (-0.51%) ▼|VZ45.98-0.70 (-1.50%) ▼|WFC80.48-0.33 (-0.41%) ▼|WMT106.80-1.93 (-1.78%) ▼|XOM161.35-1.17 (-0.72%) ▼|
18.7 C
New York
Wednesday, September 30, 2026

Tag: releases

newssourceFORcompanyinformationcontent1releasesmarket

Novogene Establishes New Subsidiary in Korea to Accelerate Multi-Omics Research

SEOUL, South Korea, June 23, 2025 /PRNewswire/ -- Novogene, a global leader in next-generation sequencing (NGS) and multi-omics solutions, today announced the establishment of...

KANEKA UBIQUINOL™ WINS COVETED MARKETING AWARD 2025 AT NATURAL HEALTH PRODUCTS NEW ZEALAND SUMMIT

SYDNEY, June 23, 2025 /PRNewswire/ -- Kaneka Corporation Supplement Division APAC, the world-renowned manufacturer and global supplier of Ubiquinol is thrilled to announce that...

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the...

New FRONTIER5 results show a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for a washout period, was well-tolerated...

Revolutionary Research by Dr. Takuma Hayashi Uncovers Molecular Origins of Deadly Uterine Cancer and Charts New Path for Treatment

In a landmark advancement for women's cancer research, Dr. Takuma Hayashi and his team have made groundbreaking discoveries that could transform our understanding and...

Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials

Results from the fixed-dose QWINT-1 study, along with the QWINT-3 and QWINT-4 studies, reinforce efsitora's potential to simplify insulin management with weekly dosing Lilly plans...

Once-Weekly Insulin Efsitora Achieves Comparable A1C Reduction to Daily Insulin Therapy

Once-weekly insulin helped patients achieve an average A1C of 6.92% in QWINT-1 trial Results support once-weekly insulin as effective alternative to daily treatment CHICAGO, June 22,...

Inhaled Insulin Shown as a Safe and Effective Replacement for Standard-of-Care in Children with Type 1 Diabetes

Findings Highlight Potential for Novel Approach to Insulin Delivery in Pediatric Population CHICAGO, June 22, 2025 /PRNewswire/ -- Today, a new study demonstrates inhaled insulin...

From Cult Thriller to Real-Life Dares: The Producers of Would You Rather Launch CAJOLE — A Platform Asking How Far You’d Go for the...

LOS ANGELES, June 22, 2025 /PRNewswire/ -- What would it take for you to be buried alive? Pour a bucket of nacho cheese over...

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable impact of RCM technology adoption DENVER, June 22, 2025 /PRNewswire/...

Cyberway Product Innovation Platform: Empowering Enterprise Innovation Processes and Building Exceptional Product Strength

GUANGZHOU , June 22, 2025 /PRNewswire/ -- In the fiercely competitive FMCG market, only efficient innovation can create a true competitive edge. As consumer preferences...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. – PTCT

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ: PTCT).  Such...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 3D Systems Corporation – DDD

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  3D Systems Corporation ("3D Systems" or the...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. – NPCE

NEW YORK, June 22, 2025 /PRNewswire/ -- APomerantz LLP is investigating claims on behalf of investors of  NeuroPace, Inc. ("NeuroPace" or the "Company") (NASDAQ:...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sable Offshore Corp. – SOC

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sable Offshore Corp. ("Sable" or the "Company")...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsReleases

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers